+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon



Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, Lyon



Human Vaccines & Immunotherapeutics 9(4): 928-931



Vaccines have had a major role in enhancing the quality of life and increasing life expectancy. Despite these successes and the development of new vaccine technologies, there remain multiple infectious diseases including AIDS, malaria and tuberculosis that require effective prophylactic vaccines. New and traditional technologies have a role in the development and delivery of the new vaccine candidates. The scientific challenges, opportunities and funding models for developing vaccines for low resource settings are highlighted here.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055666370

Download citation: RISBibTeXText

PMID: 23322007

DOI: 10.4161/hv.23514


Related references

Challenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon. Human Vaccines & Immunotherapeutics 9(4): 924-927, 2014

Healthcare in the developing world: opportunities in emerging markets. Healthcare in the developing world: opportunities in emerging markets: viii + 112 pp., 1995

Emerging markets & emerging needs: developing countries vaccine manufacturers' perspective & its current status. Biologicals 37(3): 165-168, 2009

Partnering for Vaccine Emerging Markets--Berlin, June 10-11, 2013: balancing vaccine quality, capacity, and cost-of-goods in emerging markets. Human Vaccines and Immunotherapeutics 9(9): 2022-2024, 2013

Exchange Rate Challenges in Emerging Markets and Developing Countries-Introduction. Review of Development Economics 19(3): 449-454, 2015

Emerging markets. Developing countries offer burgeoning opportunities for private-sector investment. Modern Healthcare 27(44): I28 I30, 1997

Blood Supply and Safety in the Developing World Considerations for Emerging Markets. 2012

Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases. Developments in Biologicals 114: 243-250, 2003

Emerging technologies in emerging markets: Introduction to the special section. Technological Forecasting and Social Change 78(7): 1101-1103, 2011

Export opportunities in world markets for honey from developing countries. Proceedings Development of world apicultural trade: ub 1978) 13-20, 1978

Export opportunities in world markets for beeswax from developing countries. Proceedings Development of world apicultural trade: ub 1978) 21-27, 1978

Emerging zoonoses - new challenges. Proceedings of the 18th Nordic Committee for Veterinary Scientific Cooperation (NKVet), Uppsala, Sweden, 7-8 October 2004. Acta Veterinaria Scandinavica, Suppl. (Suppl. 100): 37-78, 2004

Opportunities and challenges for expatriates in emerging markets: an exploratory study of Korean expatriates in India. International Journal of Human Resource Management  24(5): 1029-1050, 2013

Winning the race for talent in emerging markets. New research shows how to attract and retain the best employees in developing economies. Harvard Business Review 86(11): 62-70, 2008

New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine 31(Suppl. 1): A1-20, 2014